CBP40150MTAP (CN=1) CDKN2A (CN=1) CDKN2B (CN=1) co-loss Re
cobioer/科佰生物 品牌
代理商厂商性质
南京市所在地
HLA-B*13:01 Reference Standard
面议HLA-B*58:01 Reference Standard
面议HLA-B*15:02 Reference Standard
面议HLA-B*57:01 Reference Standard
面议HLA-B*27:05 Reference Standard
面议HLA-B*27:04 Reference Standard
面议EML4(E13)-ALK(E20) Translocation
面议PNPLA3 p.I148M Reference Standard 用药
面议PNPLA3 p.I148M Reference Standard 用药
面议PNPLA3 WT Reference Standard 用药指导
面议FLT3 p.G583_Y599dup Reference Standard
面议PIK3CA p.G1049R Reference Standard
面议| MTAP (CN=1) CDKN2A (CN=1) CDKN2B (CN=1) co-loss Reference Standard | ||||
| Introduction | ||||
| Format | Genomic DNA | |||
| Description | MTAP loss has been commonly observed in multiple malignancies, including gliomas, pancreatic cancer, mesothelioma and non-small cell lung cancer (NSCLC). CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) is a Protein Coding gene. Diseases associated with CDKN2A include Melanoma, Cutaneous Malignant 2 and Melanoma-Pancreatic Cancer Syndrome. CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) is a Protein Coding gene. Diseases associated with CDKN2B include Lipoprotein Quantitative Trait Locus and Ovarian Cancer. | |||
| Technical Data | ||||
| Definition | Loss | |||
| Copy Number | 1.00 | |||
| DdPCR | 0.91(CDKN2A) 0.92(CDKN2B) 1.00(MTAP) | |||
| Product Information | ||||
| Intended Use | Research Use Only | |||
| Unit Size | 1ug | |||
| Concentration | Download for COA | |||
| Purity | Download for COA | |||
| DNA electrophoresis | Download for COA | |||
| Sanger sequencing | Download for COA | |||
| Storage | 4℃ | |||
| Expiry | 36 months from the date of manufacture | |||
